KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Asset Utilization Ratio (2019 - 2025)

Historic Asset Utilization Ratio for Castle Biosciences (CSTL) over the last 7 years, with Q3 2025 value amounting to 0.62.

  • Castle Biosciences' Asset Utilization Ratio fell 35.75% to 0.62 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.62, marking a year-over-year decrease of 35.75%. This contributed to the annual value of 0.67 for FY2024, which is 3821.04% up from last year.
  • As of Q3 2025, Castle Biosciences' Asset Utilization Ratio stood at 0.62, which was down 35.75% from 0.66 recorded in Q2 2025.
  • Castle Biosciences' 5-year Asset Utilization Ratio high stood at 0.67 for Q1 2025, and its period low was 0.16 during Q1 2021.
  • Over the past 5 years, Castle Biosciences' median Asset Utilization Ratio value was 0.39 (recorded in 2023), while the average stood at 0.41.
  • In the last 5 years, Castle Biosciences' Asset Utilization Ratio crashed by 6924.28% in 2021 and then surged by 6503.51% in 2023.
  • Over the past 5 years, Castle Biosciences' Asset Utilization Ratio (Quarter) stood at 0.21 in 2021, then soared by 44.23% to 0.3 in 2022, then soared by 63.23% to 0.49 in 2023, then grew by 28.49% to 0.64 in 2024, then dropped by 2.31% to 0.62 in 2025.
  • Its Asset Utilization Ratio was 0.62 in Q3 2025, compared to 0.66 in Q2 2025 and 0.67 in Q1 2025.